fashion -WSS

fashion

author：entertainment 2025-09-29 16:21:08 - browse：1521

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

hotspot

WSS

FDA endorses new sterilization method for medical devices

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Update the Apgar Score to remove skin color

Medicare bonuses could stop drug shortages under Senate plan

To bolster infectious disease surveillance, genomics powerhouses team up

Head of FDA's diagnostics center, who led through Covid, retires

knowledge

fashion

entertainment

Heart attack and stroke risk calculators need revising

Maisha Meds is a PBM, but don't call it that

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The pink breast cancer awareness ribbon needs a redesign

Jerome Adams on the need for new antivirals for Covid

HPV vaccine, cervical cancer study delivers historic results

State Dept. review finds Biden bears some blame for Afghanistan failures

Testing for cancer recurrence creates a new limbo for patients

Heart attack and stroke risk calculators need revising

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Wikipedia

Future doctors need a strong humanities education

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Traditional Chinese medicine benefits explored in new JAMA study

Biden's order seeks to regulate AI risk without stifling innovation

Flu vaccine reformulation won't be easy, manufacturers warn

High breast density mammograms need follow

hotspot

leisure time

focus

entertainment